Top Markets
Coin of the day
CSL Limited CSL Limited

CSL Limited

CSL
株式のランク #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
株価
$99.32
時価総額
$48.20B
変化(1日)
0.98%
変化(1年)
-32.14%
AU
取引 CSL Limited (CSL)

カテゴリー

CSL Limited(CSL)のEPS
December 2025 時点のEPS TTM: $2.98
CSL Limitedの最新の財務報告と株価によると、同社の現在のEPS(TTM)は$2.98です。2024年末には、EPSは$5.47で、2023年のEPS$4.55と増加でした。
CSL LimitedのEPS履歴(2000から2026まで)
各年末時点のEPS
EPS 変化
2026 (TTM) $2.98 -51.94%
2025 $6.20 13.35%
2024 $5.47 20.22%
2023 $4.55 -31.37%
2022 $6.63 26.05%
2021 $5.26 13.61%
2020 $4.63 9.20%
2019 $4.24 50.89%
2018 $2.81 -4.42%
2017 $2.94 9.29%
2016 $2.69 -7.88%
2015 $2.92 8.15%
2014 $2.70 21.09%
2013 $2.23 12.45%
2012 $1.98 -0.58%
2011 $1.99 49.05%
2010 $1.34 6.70%
2009 $1.25 7.16%
2008 $1.17 64.09%
2007 $0.71 500.34%
2006 $0.12 -78.01%
2005 $0.54 168.22%
2004 $0.20 202.40%
2003 $0.07 -21.18%
2002 $0.08 -5.06%
2001 $0.09 83.13%
2000 $0.05 0.00%
同様の企業または競合他社のEPS
企業 EPS EPSの差
$3.62 21.55%
DK
$15.47 419.13%
US
$43.12 1,346.98%
US
$9.62 222.85%
BE
$38.32 1,185.91%
NL